Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui Shao

Showing results (611-620 of 618) with videos related to

Pageof 62
Sort By:
You have reached the last page of results.This site can display upto 618 results.
Clinical & Translational Immunology|February 9, 2022
Allogeneic CD20-targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B-cell lymphoma modelsKevin P Nishimoto, Taylor Barca, Aruna Azameera, et al.
Trials|November 28, 2024
Comparisons of efficacy and safety of 400 or 800 ml bacterial count fecal microbiota transplantation in the treatment of recurrent hepatic encephalopathy: a multicenter prospective randomized controlled trial in ChinaPengfei Zou, Yunjiao Bi, Zhaowei Tong, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 16, 2021
Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life ChallengeMichelle Tew, Michael Willis, Christian Asseburg, et al.
The Lancet. Haematology|December 7, 2024
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trialModupe Idowu, Lucas Otieno, Bogdan Dumitriu, et al.
Diabetes Technology & Therapeutics|June 5, 2026
Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe UseSatish K Garg, Halis K Akturk, Samita Garg, et al.
Science Translational Medicine|August 28, 2015
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivoLaura R Saunders, Alexander J Bankovich, Wade C Anderson, et al.
Journal of the American Medical Informatics Association : JAMIA|December 24, 2025
Multi-site analysis of COVID-19 and new-onset diabetes reveals need for improved sensitivity of EHR-based COVID-19 phenotypes-a DiCAYA network analysisSarah Conderino, H Lester Kirchner, Lorna E Thorpe, et al.
Diabetes Care|March 31, 2025
Developing a Computable Phenotype for Identifying Children, Adolescents, and Young Adults With Diabetes Using Electronic Health Records in the DiCAYA NetworkHui Shao, Lorna E Thorpe, Shahidul Islam, et al.
Pageof 62

Showing results (611-620 of 618) with videos related to

Sort By:
Pageof 62
You have reached the last page of results.This site can display upto 618 results.
Clinical & Translational Immunology|February 9, 2022
Allogeneic CD20-targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B-cell lymphoma modelsKevin P Nishimoto, Taylor Barca, Aruna Azameera, et al.
Trials|November 28, 2024
Comparisons of efficacy and safety of 400 or 800 ml bacterial count fecal microbiota transplantation in the treatment of recurrent hepatic encephalopathy: a multicenter prospective randomized controlled trial in ChinaPengfei Zou, Yunjiao Bi, Zhaowei Tong, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 16, 2021
Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life ChallengeMichelle Tew, Michael Willis, Christian Asseburg, et al.
The Lancet. Haematology|December 7, 2024
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trialModupe Idowu, Lucas Otieno, Bogdan Dumitriu, et al.
Diabetes Technology & Therapeutics|June 5, 2026
Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe UseSatish K Garg, Halis K Akturk, Samita Garg, et al.
Science Translational Medicine|August 28, 2015
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivoLaura R Saunders, Alexander J Bankovich, Wade C Anderson, et al.
Journal of the American Medical Informatics Association : JAMIA|December 24, 2025
Multi-site analysis of COVID-19 and new-onset diabetes reveals need for improved sensitivity of EHR-based COVID-19 phenotypes-a DiCAYA network analysisSarah Conderino, H Lester Kirchner, Lorna E Thorpe, et al.
Diabetes Care|March 31, 2025
Developing a Computable Phenotype for Identifying Children, Adolescents, and Young Adults With Diabetes Using Electronic Health Records in the DiCAYA NetworkHui Shao, Lorna E Thorpe, Shahidul Islam, et al.
Pageof 62